PCRX icon

Pacira BioSciences
PCRX

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$31
60% upside
High target

4 analyst ratings

positive
1  neutral
25%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Douglas Tsao
50% 1-yr PCRX win rate
9 Jan ‘26 7 days ago
Needham
Needham
Serge Belanger
50% 1-yr PCRX win rate
9 Jan ‘26 7 days ago
Barclays
Barclays
Glen Santangelo
9 Dec ‘25 1 month ago
Truist Securities
Truist Securities
Les Sulewski
0% 1-yr PCRX win rate
7 Nov ‘25 2 months ago